- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Pharmacokinetics, Plasma Concentrations & (Their) Clinical Relevance

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Pharmacokinetics, Plasma Concentrations & (Their) Clinical Relevance
Pharmacokinetics refers to the study of how drugs are processed by the body. These processes play an important role in mental health treatments, and can vary due to several factors, ultimately impacting treatment of mental health. In this webinar, we will first provide an overview of pharmacokinetics and pharmacodynamics. Then, we will discuss the differences between pharmacokinetics based on different medication formulations, including the differences between oral and long-acting injectable formulations. Finally, the importance of pharmacokinetics and plasma concentration monitoring will be discussed as it relates to the clinical setting.

Stephen R. Saklad, PharmD, BCPP
Director, Psychiatric Pharmacy Program, UT Health Science Center San Antonio; Clinical Professor, UTHSCSA, School of Medicine, Pharmacotherapy Education & Research Center, The University of Texas at Austin College of Pharmacy; and Clinical Pharmacologist, San Antonio State Hospital, Texas Department of State Health Services
More

Dennis Pabis, PharmD, BCPP (OPDC)
Senior Medical Science Liaison
Speaker Stephen R. Saklad, PharmD, BCPP is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Speaker Dennis Pabis, PharmD, BCPP is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)